Does ENALAPRIL Cause Salivary hypersecretion? 5 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Salivary hypersecretion have been filed in association with ENALAPRIL (Enalapril maleate oral solution). This represents 0.1% of all adverse event reports for ENALAPRIL.
5
Reports of Salivary hypersecretion with ENALAPRIL
0.1%
of all ENALAPRIL reports
0
Deaths
0
Hospitalizations
How Dangerous Is Salivary hypersecretion From ENALAPRIL?
Of the 5 reports.
Is Salivary hypersecretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENALAPRIL. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does ENALAPRIL Cause?
Acute kidney injury (916)
Drug ineffective (599)
Hypotension (556)
Dyspnoea (514)
Hypertension (451)
Hyperkalaemia (448)
Drug interaction (441)
Angioedema (412)
Off label use (347)
Diarrhoea (342)
What Other Drugs Cause Salivary hypersecretion?
CLOZAPINE (1,349)
ARIPIPRAZOLE (497)
RISPERIDONE (485)
OLANZAPINE (449)
QUETIAPINE (299)
CARBIDOPA\LEVODOPA (248)
HALOPERIDOL (216)
DIAZEPAM (185)
CLONAZEPAM (179)
LORAZEPAM (165)
Which ENALAPRIL Alternatives Have Lower Salivary hypersecretion Risk?
ENALAPRIL vs ENALAPRIL\HYDROCHLOROTHIAZIDE
ENALAPRIL vs ENALAPRIL\LERCANIDIPINE
ENALAPRIL vs ENASIDENIB
ENALAPRIL vs ENBREL
ENALAPRIL vs ENCORAFENIB